top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
SFT1021
Soft tissue tumor tissue array, 102 cases of benign and malignant tumors of various soft tissues.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$289
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_057f898694ac41b6b0cceed0147dacb3~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_e238eb870de14ba1bfe715120c3a0db5~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_26b2859a72db4272aeda97afc5dea006~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_46d373d63a5f448db97276a37e08652d~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_b0711f7b1db94da2899a4c9c66e1be41~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_8e9686ea75c742a4b556fed8b8c79e26~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_3f99a7164d184255b6cfbf8e0ad2b7b9~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_b0ed4355dad14b6cb410ab28bb972ee4~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_d0713abcd343487483006c106ecaa0c4~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_539badecaa654f519085e19e196f59dc~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_47560b02b64d4fa4ac75d4674c1a1258~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_d99d00baaca744559c872d17b7e2af67~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
![UNC241A-C02.jpg](https://static.wixstatic.com/media/3145b3_a62b5961367e495190a8b13e23483add~mv2_d_1600_1200_s_2.jpg/v1/fill/w_543,h_407,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/UNC241A-C02.jpg)
Human
102
102
1.5mm
4um
8
13
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in various soft tissue tumors.
![4X6b.jpg](https://static.wixstatic.com/media/3145b3_1338587bb1e74562bbb151dd34f50b4e~mv2.jpg/v1/fill/w_246,h_80,al_c,q_80,usm_2.00_1.00_0.00,enc_auto/4X6b.jpg)
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
---|---|---|---|---|---|---|---|
A01 | M | 44 | Bone, fibula | Giant cell tumor | I | ||
A02 | M | 40 | Bone, tibia | Giant cell tumor | I | ||
A03 | M | 53 | Bone | Giant cell tumor | I | ||
A04 | M | 53 | Bone, ulna | Giant cell tumor | I | ||
A05 | M | 47 | Bone, ulna | Giant cell tumor | I~II | ||
A06 | M | 30 | Bone | Giant cell tumor | I~II | ||
A07 | F | 31 | Bone, fibula | Giant cell tumor | I~II | ||
A08 | F | 13 | Bone, fibula | Giant cell tumor | I~II | ||
A09 | F | 38 | Bone, femur | Giant cell tumor | I~II | ||
A10 | M | 54 | Bone | Giant cell tumor | II | ||
A11 | F | 22 | Bone, temporal bone | Giant cell tumor | III | ||
A12 | F | 20 | Bone, humerus | Osteosarcoma | |||
A13 | M | 22 | Intestine, ileum | Osteosarcoma | |||
B01 | M | 17 | Bone, tibia | Osteosarcoma | |||
B02 | M | 22 | Bone | Osteosarcoma | |||
B03 | M | 21 | Bone, femur | Osteosarcoma | |||
B04 | M | 16 | Head and neck, mandible | Ameloblastoma | |||
B05 | F | 38 | Head and neck, mandible | Ameloblastoma | |||
B06 | M | 39 | Inguen | Chondroma | |||
B07 | M | 34 | Head and neck, ethmoid sinus | Chondrosarcoma | |||
B08 | F | 44 | Bone, humerus | Chondrosarcoma | |||
B09 | M | 44 | Bone, scapula | Chondrosarcoma | |||
B10 | M | 24 | Chest wall | Chondrosarcoma | |||
B11 | F | 70 | Bone, femur | Metastatic adenocarcinoma, thyroid adenocarciinoma? | |||
B12 | M | 61 | Bone, skull | Metastatic carcinoma | |||
B13 | M | 50 | Bone, femur | Metastatic carcinoma | |||
C01 | M | 76 | Bone | Metastatic carcinoma | |||
C02 | M | 65 | Bone, femur | Metastatic carcinoma | |||
C03 | F | 33 | Trunk | Lipoma | |||
C04 | M | 49 | Leg | Liposarcoma | |||
C05 | M | 70 | Leg | Liposarcoma | |||
C06 | M | 47 | Leg | Liposarcoma | |||
C07 | M | 54 | Leg | Liposarcoma | |||
C08 | M | 39 | Leg | Liposarcoma | |||
C09 | M | 71 | Leg | Liposarcoma | |||
C10 | M | 39 | Leg | Liposarcoma | |||
C11 | M | 50 | Leg | Liposarcoma | |||
C12 | M | 43 | Peritoneal cavity, posterior | Liposarcoma | |||
C13 | F | 66 | Peritoneal cavity, posterior | Liposarcoma | |||
D01 | F | 45 | Peritoneal cavity | Liposarcoma | |||
D02 | F | 71 | Peritoneal cavity, posterior | Liposarcoma | |||
D03 | F | 64 | Peritoneal cavity | Liposarcoma | |||
D04 | F | 74 | Trunk | Liposarcoma | |||
D05 | M | 57 | Trunk | Liposarcoma | |||
D06 | M | 38 | Trunk | Liposarcoma | |||
D07 | M | 41 | Inguen | Liposarcoma | |||
D08 | F | 35 | Leg | Fibroma | |||
D09 | F | 35 | Abdomen wall | Fibroma | |||
D10 | M | 45 | Chest wall | Fibrosarcoma | |||
D11 | M | 37 | Leg | Fibrosarcoma | |||
D12 | M | 47 | Leg | Fibrosarcoma | |||
D13 | F | 31 | Leg | Fibrosarcoma | |||
E01 | M | 56 | Leg | Fibrosarcoma | |||
E02 | M | 39 | Head and neck, neck | Fibrosarcoma | |||
E03 | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
E04 | M | 44 | Chest wall | Fibrosarcoma | |||
E05 | M | 43 | Chest wall | Fibrosarcoma | |||
E06 | M | 35 | Abdomen wall | Fibrosarcoma | |||
E07 | M | 44 | Abdomen wall | Fibrosarcoma | |||
E08 | M | 33 | Abdomen wall | Fibrosarcoma | |||
E09 | M | 24 | Abdomen wall | Fibrosarcoma | |||
E10 | M | 49 | Abdomen wall | Fibrosarcoma | |||
E11 | M | 34 | Abdomen wall | Fibrosarcoma | |||
E12 | F | 50 | Shoulder | Fibrosarcoma | |||
E13 | F | 79 | Trunk | Fibrosarcoma | |||
F01 | M | 59 | Trunk | Fibrosarcoma | |||
F02 | F | 20 | Bone, tibia | Fibrosarcoma | |||
F03 | M | 56 | Trunk | Fibrosarcoma | |||
F04 | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
F05 | M | 50 | Shoulder | Dermatofibrosarcoma protuberans | |||
F06 | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | |||
F07 | M | 33 | Brain | Malignant fibrous histiocytoma | |||
F08 | M | 35 | Bone, fibula | Malignant fibrous histiocytoma | |||
F09 | M | 34 | Bone, sacrum | Malignant fibrous histiocytoma | |||
F10 | M | 46 | Lung | Malignant fibrous histiocytoma | |||
F11 | M | 44 | Peritoneal cavity, posterior | Rhabdomyosarcoma | |||
F12 | M | 5 | Bladder, urinary | Rhabdomyosarcoma, embryonal | |||
F13 | M | 18 | Head and neck, neck | Rhabdomyosarcoma, embryonal | |||
G01 | F | 32 | Lymph node | Rhabdomyosarcoma, embryonal | |||
G02 | M | 33 | Chest wall | Aveolar rhabdomyosarcoma | |||
G03 | M | 32 | Leg | Aveolar rhabdomyosarcoma | |||
G04 | M | 43 | Arm | Aveolar rhabdomyosarcoma | |||
G05 | M | 53 | Chest wall | Rhabdomyosarcoma, polymorphic | |||
G06 | F | 65 | Leg | Rhabdomyosarcoma, polymorphic | |||
G07 | M | 77 | Arm | Rhabdomyosarcoma, polymorphic | |||
G08 | M | 62 | Leg | Leiomyosarcoma | |||
G09 | F | 63 | Peritoneal cavity | Leiomyosarcoma | |||
G10 | F | 46 | Inguen | Leiomyosarcoma | |||
G11 | M | 36 | Peritoneal cavity, posterior | Leiomyosarcoma | |||
G12 | F | 43 | Peritoneal cavity | Leiomyosarcoma | |||
H01 | F | 45 | Peritoneal cavity | Leiomyosarcoma | |||
H02 | F | 36 | Peritoneal cavity, posterior | Leiomyosarcoma | |||
H03 | M | 44 | Chest wall | Leiomyosarcoma | |||
H04 | F | 47 | Peritoneal cavity | Leiomyosarcoma | |||
H05 | M | 21 | Head and neck, larynx | Synovial sarcoma | |||
H06 | M | 28 | Leg, popliteal fossa | Synovial sarcoma | |||
H07 | M | 23 | Abdomen wall | Synovial sarcoma | |||
H08 | M | 67 | Hand | Epithelioid sarcoma | |||
H09 | M | 72 | Hand | Epithelioid sarcoma | |||
H10 | M | 61 | Peritoneal cavity | Spindle cell sarcoma | |||
H11 | F | 29 | Leg | Clear cell sarcoma | |||
H12 | F | 58 | Peritoneal cavity | Carcinosarcoma | |||
null |
bottom of page